Glioma Prognostic Panel Test
Introduction
The Glioma Prognostic Panel Test is an advanced diagnostic tool designed to evaluate the prognosis of gliomas, a type of tumor that occurs in the brain and spinal cord. This test employs cutting-edge methods, including PCR (Polymerase Chain Reaction) and Next Generation Sequencing, to analyze specific genetic markers associated with glioma. Understanding the prognosis of gliomas is crucial for tailoring treatment plans and improving patient outcomes.
What the Test Measures
This test specifically measures the presence of genetic mutations in the tumor tissue, focusing on key components such as:
- IDH1
- IDH2
- MGMT
These markers provide valuable insights into the tumor’s behavior and potential response to treatment, aiding oncologists in making informed clinical decisions.
Who Should Consider This Test
The Glioma Prognostic Panel Test is recommended for individuals diagnosed with gliomas or those exhibiting symptoms such as:
- Persistent headaches
- Seizures
- Changes in vision or speech
- Unexplained neurological deficits
Patients with a family history of brain cancer or genetic predispositions may also benefit from this test.
Benefits of Taking the Test
- Accurate prognosis assessment for glioma patients.
- Guides treatment planning and management decisions.
- Identifies potential clinical trial opportunities based on genetic markers.
- Enhances communication between patients and healthcare providers regarding treatment options.
Understanding Your Results
Results from the Glioma Prognostic Panel Test are typically available within 15 working days after sample submission. The findings will be discussed with you by your oncologist, who will explain the implications of the results and recommend the best course of action. It is essential to understand that genetic markers play a significant role in your treatment plan and overall prognosis.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Glioma Prognostic Panel Test | 42,000 KSh | 50,000 KSh |
Sample Collection and Instructions
To perform the Glioma Prognostic Panel Test, please submit a formalin-fixed paraffin-embedded (FFPE) tissue block. Ensure that the block contains at least 5% tumor tissue and ship it at room temperature. No special preparation is required before the test.
Branches Across Kenya
We have branches located in all major cities across Kenya, making it convenient for you to access our services. Additionally, we offer home sample collection services for your convenience.
Book Your Test Today!
Don’t wait to get the answers you need. Contact us at +254746849631 to book the Glioma Prognostic Panel Test today!
